XML 22 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Unaudited Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2017   60,623,000 3,621,000        
Beginning balance at Dec. 31, 2017 $ 265,258 $ 6 $ (33,064) $ 336,067 $ (884) $ (37,225) $ 358
Increase (Decrease) in Equity [Roll Forward]              
Net income 67         67  
Foreign currency translation adjustment (179)       (179)    
Stock issued under employee stock purchase plan (in shares)     (28,000)        
Stock issued under employee stock purchase plan 146     146      
Restricted stock granted (in shares)   538,000          
Restricted stock forfeited (in shares)     5,000        
Treasury stock purchased (in shares)     1,000        
Treasury stock purchased (3)   $ (3)        
Stock compensation expense 1,924     1,924      
Ending balance (in shares) at Mar. 31, 2018   61,161,000 3,599,000        
Ending balance at Mar. 31, 2018 267,213 $ 6 $ (33,067) 338,137 (1,063) (37,158) 358
Beginning balance (in shares) at Dec. 31, 2018   62,163,000 3,770,000        
Beginning balance at Dec. 31, 2018 201,624 $ 6 $ (33,237) 343,536 (1,116) (107,565) 0
Increase (Decrease) in Equity [Roll Forward]              
Net income 32,992         32,992  
Foreign currency translation adjustment $ 94       94    
Restricted stock granted (in shares) 36,037 36,000          
Restricted stock forfeited (in shares)     34,000        
Treasury stock purchased (in shares)     41,000        
Treasury stock purchased $ (131)   $ (131)        
Stock compensation expense 468     468      
Ending balance (in shares) at Mar. 31, 2019   62,199,000 3,845,000        
Ending balance at Mar. 31, 2019 $ 235,047 $ 6 $ (33,368) $ 344,004 $ (1,022) $ (74,573) $ 0